M. Herlyn and K. Satyamoorthy, Activated ras. Yet another player in melanoma?, Am J Pathol, vol.149, pp.739-783, 1996.

M. Brose, P. Volpe, M. Feldman, M. Kumar, I. Rishi et al., BRAF and RAS mutations in human lung cancer and melanoma, Cancer Res, vol.62, pp.6997-7000, 2002.

H. Davies, . Bignell, . Gr, C. Cox, P. Stephens et al., Mutations of the BRAF gene in human cancer, Nature, vol.7, issue.6892, pp.949-54, 2002.
DOI : 10.1006/geno.2000.6354

J. Villanueva and M. Herlyn, Melanoma and the tumor microenvironment, Current Oncology Reports, vol.23, issue.5, pp.439-485, 2008.
DOI : 10.1007/s11912-008-0067-y

M. Demierre, Epidemiology and prevention of cutaneous melanoma, Current Treatment Options in Oncology, vol.12, issue.3, pp.181-187, 2006.
DOI : 10.1007/s11864-006-0011-z

T. Chang and E. Szabo, Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer, Cancer Res, vol.60, pp.1129-1167, 2000.

C. Grommes, . Landreth, and M. Heneka, Antineoplastic effects of peroxisome proliferatoractivated receptor ?? agonists, The Lancet Oncology, vol.5, issue.7, pp.419-448, 2004.
DOI : 10.1016/S1470-2045(04)01509-8

J. Hisatake, T. Ikezoe, M. Carey, S. Holden, . Tomoyasu et al., Down- Regulation of prostate-specific antigen expression by ligands for peroxisome proliferatoractivated receptor gamma in human prostate cancer, Cancer Res, vol.60, pp.5494-5502, 2000.

T. Kubota, K. Koshizuka, . Williamson, . Ea, H. Asou et al., Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo Differentiation and reversal of malignant changes in colon cancer through PPARgamma, Cancer Res. Nat Med, vol.58, issue.4, pp.3344-52, 1998.

M. Toyoda, H. Takagi, N. Horiguchi, S. Kakizaki, K. Sato et al., A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells, Gut, vol.50, issue.4, pp.563-570, 2002.
DOI : 10.1136/gut.50.4.563

H. Haghnegahdar, J. Du, D. Wang, R. Strieter, . Burdick et al., The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma, J Leukoc Biol, vol.67, pp.53-62, 2000.

J. Luan, R. Shattuck-brandt, H. Haghnegahdar, J. Owen, R. Strieter et al., Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression, J Leukoc Biol, vol.62, pp.588-97, 1997.

R. Bordoni, R. Fine, R. Murray, and A. , Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes, Journal of Cellular Biochemistry, vol.243, issue.4, pp.207-226, 1990.
DOI : 10.1002/jcb.240440403

P. Dhawan and A. Richmond, Role of CXCL1 in tumorigenesis of melanoma, J Leukoc Biol, vol.72, pp.9-18, 2002.

C. Hodgkinson, . Moore, . Kj, A. Nakayama, E. Steingrimsson et al., Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein, Cell, vol.74, issue.2, pp.395-404, 1993.
DOI : 10.1016/0092-8674(93)90429-T

C. Bertolotto, P. Abbe, . Hemesath, . Tj, K. Bille et al., Microphthalmia Gene Product as a Signal Transducer in cAMP-Induced Differentiation of Melanocytes, The Journal of Cell Biology, vol.269, issue.3, pp.827-862, 1998.
DOI : 10.1038/255644a0

A. Hughes, . Newton, . Ve, . Liu, . Xz et al., A gene for Waardenburg Syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12???p14.1, Nature Genetics, vol.1, issue.4, pp.509-521, 1994.
DOI : 10.1038/355637a0

E. Steingrimsson, . Copeland, . Ng, and N. Jenkins, Transcription Factor Network, Annual Review of Genetics, vol.38, issue.1, pp.365-411, 2004.
DOI : 10.1146/annurev.genet.38.072902.092717

L. Garraway, . Widlund, . Hr, M. Rubin, G. Getz et al., Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma, Nature, vol.64, issue.7047, pp.117-139, 2005.
DOI : 10.1038/nature03664

M. Grabacka, W. Placha, K. Urbanska, P. Laidler, . Plonka et al., PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91 PPARgamma agonists attenuate proliferation and modulate Wnt/beta-catenin signalling in melanoma cells, Pigment Cell Melanoma Res Int J Biochem Cell Biol, vol.21, issue.41, pp.388-96, 2008.

C. Freudlsperger, I. Moll, . Schumacher, and A. Thies, Anti-proliferative effect of peroxisome proliferator-activated receptor ?? agonists on human malignant melanoma cells in vitro, Anti-Cancer Drugs, vol.17, issue.3, pp.325-357, 2006.
DOI : 10.1097/00001813-200603000-00011

H. Kang, . Lee, . Jy, . Lee, Y. Choi et al., Peroxisome proliferator-activated receptors-?? activator, ciglitazone, inhibits human melanocyte growth through induction of apoptosis, Archives of Dermatological Research, vol.118, issue.10, pp.472-478, 2003.
DOI : 10.1007/s00403-006-0646-4

Y. Ueda and A. Richmond, NF-kappaB activation in melanoma, Pigment Cell Research, vol.157, issue.2, pp.112-136, 2006.
DOI : 10.1038/sj.bjc.6602598

A. Richmond and S. Yang, The good and the bad of chemokines/chemokine receptors in melanoma, Pigment Cell & Melanoma Research, vol.7, issue.2, 2009.
DOI : 10.1111/j.1755-148X.2009.00554.x

A. Zlotnik, Y. , and O. , Chemokines, Immunity, vol.12, issue.2, pp.121-128, 2000.
DOI : 10.1016/S1074-7613(00)80165-X

A. Payne and L. Cornelius, The Role of Chemokines in Melanoma Tumor Growth and Metastasis, Journal of Investigative Dermatology, vol.118, issue.6, pp.915-937, 2002.
DOI : 10.1046/j.1523-1747.2002.01725.x

J. Yang, J. Luan, Y. Yu, C. Li, . Depinho et al., Induction of melanoma in murine macrophage inflammatory protein 2 transgenic mice heterozygous for inhibitor of kinase/alternate reading frame, Cancer Res, vol.61, pp.8150-8157, 2001.

G. Dong, E. Loukinova, Z. Chen, L. Gangi, . Chanturita et al., Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-kappaB signal pathway Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells, Cancer Res J Immunol, vol.61, issue.156, pp.4797-808, 1996.

D. Lawson, . Thomas, . Hg, R. Roy, . Gordon et al., Preparation of a monoclonal antibody to a melanoma growth-stimulatory activity released into serum-free culture medium by Hs0294 malignant melanoma cells, Journal of Cellular Biochemistry, vol.119, issue.3, pp.169-85, 1987.
DOI : 10.1002/jcb.240340304

M. Caunt, L. Hu, T. Tang, . Brooks, . Pc et al., Growth-Regulated Oncogene Is Pivotal in Thrombin-Induced Angiogenesis, Cancer Research, vol.66, issue.8, pp.4125-4157, 2006.
DOI : 10.1158/0008-5472.CAN-05-2570

D. Wang, H. Wang, J. Brown, T. Daikoku, W. Ning et al., promotes angiogenesis in colorectal cancer, The Journal of Experimental Medicine, vol.13, issue.4, pp.941-51, 2006.
DOI : 10.1210/me.15.11.1983

D. Kelly, J. Campbell, . King, . Tp, G. Grant et al., Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-?? and RelA, Nature Immunology, vol.5, issue.1, pp.104-116, 2004.
DOI : 10.1038/ni1018

M. Ricote, A. Li, . Willson, . Tm, . Kelly et al., The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation, Nature, vol.391, issue.6662, pp.79-82, 1998.
DOI : 10.1038/34178

L. Wang, . Yang, . Xy, . Zhang, and W. Farrar, Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPAR?? cross talk with NF-??B and C/EBP, Blood, vol.110, issue.13, pp.4373-84, 2007.
DOI : 10.1182/blood-2006-07-038026

L. Larribere, C. Hilmi, M. Khaled, C. Gaggioli, K. Bille et al., The cleavage of microphthalmia-associated transcription factor, MITF, by caspases plays an essential role in melanocyte and melanoma cell apoptosis, Genes & Development, vol.19, issue.17, pp.1980-1985, 2005.
DOI : 10.1101/gad.335905

C. Gaggioli, G. Robert, C. Bertolotto, O. Bailet, P. Abbe et al., Tumor-Derived Fibronectin Is Involved in Melanoma Cell Invasion and Regulated by V600E B-Raf Signaling Pathway, Journal of Investigative Dermatology, vol.127, issue.2, p.7, 2006.
DOI : 10.1038/sj.jid.5700524

L. Larribere, M. Khaled, S. Tartare-deckert, R. Busca, F. Luciano et al., PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes, Cell Death and Differentiation, vol.11, issue.10, pp.1084-91, 2004.
DOI : 10.1038/sj.cdd.4401475

G. Li, K. Satyamoorthy, F. Meier, C. Berking, and H. Bogenrieder, Function and regulation of melanoma???stromal fibroblast interactions: when seeds meet soil, Oncogene, vol.22, issue.20, pp.3162-71, 2003.
DOI : 10.1038/sj.onc.1206455

L. Beuret, E. Flori, C. Denoyelle, K. Bille, R. Busca et al., Up-regulation of MET Expression by ??-Melanocyte-stimulating Hormone and MITF Allows Hepatocyte Growth Factor to Protect Melanocytes and Melanoma Cells from Apoptosis, Journal of Biological Chemistry, vol.282, issue.19, pp.14140-14147, 2007.
DOI : 10.1074/jbc.M611563200

C. Bertolotto, K. Bille, . Ortonne, and R. Ballotti, Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product, The Journal of Cell Biology, vol.134, issue.3, pp.747-55, 1996.
DOI : 10.1083/jcb.134.3.747

E. Miot-noirault, J. Legault, F. Cachin, E. Mounetou, F. Degoul et al., Antineoplastic potency of arylchloroethylurea derivatives in murine colon carcinoma, Investigational New Drugs, vol.22, issue.4, pp.369-78, 2004.
DOI : 10.1023/B:DRUG.0000036679.12112.4c